Tratamento
Semaglutide generics in Brazil compared: how EMS, Gevron, and Eurofarma differ in bula, pen format, price per dose, and safety reporting.
Early research suggests GLP-1 medicines may affect drinking for some people, but the evidence is still thin. Here is what researchers are studying, how trials are built, and what safety means if you drink.
Skipped your GLP-1 shot for a week or more? Here is a calm, practical way to think about restarting, checking your pen, and knowing when to call your prescriber.
Thinking about a GLP-1 pen switch? Here are the signs that often start that conversation, and what to bring to your doctor.
Ozempic afeta a função renal? Veja o que o SUSTAIN-6 e o estudo FLOW mediram, o que ainda não sabemos e o que perguntar ao médico.
Retatrutide is being called 'stronger than Mounjaro' in headlines. Here's what the trials measured, where the comparison breaks down, and what to check in Brazil.
Brazilian labs are reportedly gaining ground in semaglutide sales. Here is what that share does and doesn't tell you, and how to check the product in your hand.
A once-weekly pen that combines insulin icodec and semaglutide is getting attention in Brazil. Here's what it contains and what ANVISA registration does, and doesn't, change for people with type 2 diabetes.
Curious about what happens after reaching your weight loss goal on Ozempic? Here's what the maintenance phase really involves and what the research shows about long-term outcomes.
Wondering if you can safely take supplements while using GLP-1 weight loss pens? Here's what the current evidence actually says about vitamins, protein powders, and other common supplements alongside semaglutide and tirzepatide.
